A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment.

Carlos Alves, Ana Penedones, Diogo Mendes and Francisco Batel Marques

Acta Ophthalmol. 2016 Feb 5. doi: 10.1111/aos.12931.

2016
http://onlinelibrary.wiley.com/doi/10.1111/aos.12931/abstract;jsessionid=0857755765BEDB9128402C8C786E8567.f01t02

Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

Mendes D, Alves C, Batel Marques F

Pharmacoepidemiol Drug Saf. 2015 Sep 16. doi: 10.1002/pds.3874.

2015
http://www.ncbi.nlm.nih.gov/pubmed/26376779

The role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review

Dias P, Penedones A, Alves C, Fontes Ribeiro C, Batel Marques F

Current Drug Saf. 2015, 10(2): 000-000

2015
http://www.ncbi.nlm.nih.gov/pubmed/?term=The+role+of+Disproportionality+Analysis+of+Pharmacovigilance+Databases+in+Safety+Regulatory+Actions%3A+a+Systematic+Review

Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit

Batel Marques F, Mendes D, Alves C, Penedones A, Dias P, Martins A, Santiago LM, Fontes-Ribeiro C, Caramona M, Macedo T

Acta Med Port 2015 Mar-Apr; 28(2):222-232

2015
http://www.ncbi.nlm.nih.gov/pubmed/?term=Pharmacovigilance+in+Portugal%3A+Activity+of+the+Central+Pharmacovigilance+Unit

Drug-induced ocular adverse reactions: review of the safety alerts issued during the last decade

Penedones A, Mendes D, Alves C, Batel Marques F

J Ocul Pharmacol Ther. 2015 Jun;31(5):258-68.

2015
http://www.ncbi.nlm.nih.gov/pubmed/25871404

Segurança dos Medicamentos Biológicos Oftálmicos: Revisão Sistemática

Penedones A, Mendes D, Alves C, Batel Marques F

Rev Port Farmacoter 2015; 7: 28-44

2015

Medidas de desproporcionalidade na deteção de sinal em farmacovigilância

Dias P, Fontes Ribeiro C, Batel Marques F

Revista Portuguesa de Farmacoterapia 2014; 6: 31-35

2014

Safety monitoring of ophthalmic biologics: analysis of pre and post-marketing safety data.

Penedones A, Mendes D, Alves C, Batel Marques F.

Journal of Ocular Pharmacology and Therapeutics. 2014 doi:10.1089/jop.2013.0206

2014
http://www.ncbi.nlm.nih.gov/pubmed/25073069

Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks

Carlos Alves, Francisco Batel Marques, Ana Filipa Macedo

European Journal of Clinical Pharmacology 2014. DOI:10.1007/s00228-014-1670-5

2014

Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events.

Diogo Mendes, Carlos Alves, Francisco Batel Marques

Journal of Clinical Pharmacy and Therapeutics 2014. DOI: 10.1111/jcpt.12148

2014